SNDX

NASDAQ · Biotechnology

Syndax Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$20.40

+0.64 (+3.24%)

As of Aug 8, 10:05 PM ET ·

SNDX News1 articles

SELLAS Life Sciences Stock Jumps 12% Ahead of Key Trial Results

SELLAS Life Sciences rose 12.3% on Friday, closing at $13.19, with a market cap discrepancy of $319 million ahead of REGAL trial results.